09 Dec 2024
Cera Sanitaryware
Anand Rathi
Target
6148.50
9899.00
7822.35
(-21.40%)
61.00
Buy
Broker Report
Cera Sanitaryware’s H1 remained soft as revenue was flat at Rs8.9bn. EBITDA declined 11.4% y/y, while PAT inched up 1.7% y/y to Rs1.2bn.
02 Dec 2024
TBO Tek
Anand Rathi
1600.50
2070.00
1580.55
(1.26%)
29.33
Buy
Broker Report
TBO Tek’s H1 FY25 revenue grew ~24.7% y/y to ~Rs8.7bn (organic growth ~17.1% y/y). The overall take rate rose from ~5.2% in H1 FY24to ~5.5%, with monthly transacting buyers growing ~6.8% y/y to 28,252.
30 Nov 2024
Kewal Kiran Clothing
Anand Rathi
Target
557.65
803.00
631.90
(-11.75%)
44.00
Buy
Broker Report
Kewal Kiran’s H1 revenue grew 4.2% y/y, led by Kraus’ acquisition, though standalone sales fell 8.3% y/y on weak demand.
28 Nov 2024
Lloyds Metals & Energy
Anand Rathi
1312.30
1260.00
968.70
(35.47%)
Target met
Buy
Broker Report
The only iron ore miner in Maharashtra, Lloyds has ~157m tonnes of extractable iron ore and ~701m tonnes of banded hematite quartzite (BHQ).
26 Nov 2024
Astral
Anand Rathi
1383.60
2666.00
1782.70
(-22.39%)
92.69
Buy
Broker Report
In the extremely volatile PVC pricing context Astral’s performance was decent though revenue was up only 0.5% to a muted Rs13.7bn.
17 Nov 2024
Finolex Cables
Anand Rathi
827.85
1577.00
1137.35
(-27.21%)
90.49
Buy
Broker Report
Continuous decline in copper prices from end-May till Aug, leftover highcost Q1 inventory and destocking impacted Finolex Cables’ Q2. Multiple price cuts during Q2 dented margins.
12 Nov 2024
Jupiter Life Line
Anand Rathi
1483.80
1740.00
1542.20
(-3.79%)
Target met
Buy
Broker Report
In line with our estimates and consensus, Jupiter Lifeline Hospital reported healthy Q2 figures, with revenue/EBITDA/PAT up23%/23%/53% y/y.
12 Nov 2024
Hindalco Industries
Anand Rathi
780.35
800.00
651.65
(19.75%)
2.52
Buy
Broker Report
Hindalco Industries’ strategic expansion in Bay Minette is on track and the recently commissioned 250k tonne Guthrie facility is ramping up, with production having commenced in Q2.
12 Nov 2024
Shree Cements
Anand Rathi
29180.00
28600.00
24372.80
(19.72%)
Target met
Buy
Broker Report
Shree Cements’ Q2 was muted due to the weak demand-pricing environment, owing to prolonged monsoons and low infrastructure spends by the government.
10 Nov 2024
Emami
Anand Rathi
550.55
900.00
669.85
(-17.81%)
63.47
Buy
Broker Report
With Rs8.9bn revenue (vs. the Street’s Rs9.1bn estimate) and EBITDA atRs2.5bn (Rs2.5bn), Emami’s Q2 was broadly in line with estimates.